Page last updated: 2024-08-22

ornithylaspartate and ornithine phenylacetate

ornithylaspartate has been researched along with ornithine phenylacetate in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Sussman, NL1
Arias, N; Hadjihambi, A; Jalan, R; Sheikh, M1
Alsahhar, JS; Rahimi, RS1
Alimirah, M; Gordon, SC; Sadiq, O1

Reviews

4 review(s) available for ornithylaspartate and ornithine phenylacetate

ArticleYear
Treatment of Overt Hepatic Encephalopathy.
    Clinics in liver disease, 2015, Volume: 19, Issue:3

    Topics: Amino Acids, Branched-Chain; Ammonia; Arteriovenous Fistula; Dipeptides; Gastrointestinal Agents; Glycerol; Hepatic Encephalopathy; Humans; Lactulose; Liver Failure; Malnutrition; Ornithine; Phenylbutyrates; Probiotics; Rifamycins; Rifaximin

2015
Hepatic encephalopathy: a critical current review.
    Hepatology international, 2018, Volume: 12, Issue:Suppl 1

    Topics: Albumins; Ammonia; Anti-Bacterial Agents; Bile Acids and Salts; Brain; Brain Edema; Cognitive Dysfunction; Dipeptides; Energy Metabolism; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Ornithine; Portasystemic Shunt, Surgical; Prognosis; Psychometrics; Severity of Illness Index; Synaptic Transmission

2018
Updates on the pathophysiology and therapeutic targets for hepatic encephalopathy.
    Current opinion in gastroenterology, 2019, Volume: 35, Issue:3

    Topics: Amino Acids, Aromatic; Amino Acids, Branched-Chain; Ammonia; Dipeptides; Fecal Microbiota Transplantation; Frailty; Gastrointestinal Agents; Gastrointestinal Microbiome; Glycerol; Hepatic Encephalopathy; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Ornithine; Phenylbutyrates; Polyethylene Glycols; Probiotics; Rifaximin; Trace Elements; Zinc

2019
Novel Therapies in Hepatic Encephalopathy.
    Clinics in liver disease, 2020, Volume: 24, Issue:2

    Topics: Acetylcarnitine; Albumins; Ammonia; Dipeptides; Fecal Microbiota Transplantation; Flumazenil; GABA Modulators; Glycerol; Hepatic Encephalopathy; Humans; Nootropic Agents; Ornithine; Phenylbutyrates; Polyethylene Glycols; Probiotics; Surface-Active Agents

2020